Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P53675 (
CHC22
)
19
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CHC22
clathrin plays a key role in intracellular membrane traffic of the insulin-responsive glucose transporter GLUT4 in humans. We performed population genetic and phylogenetic analyses of the
CHC22
-encoding
CLTCL1
gene, revealing independent gene loss in at least two vertebrate lineages, after arising from gene duplication. All vertebrates retained the paralogous
CLTC
gene encoding CHC17 clathrin, which mediates endocytosis. For vertebrates retaining
CLTCL1
, strong evidence for purifying selection supports
CHC22
functionality. All human populations maintained two high frequency
CLTCL1
allelic variants, encoding either methionine or
valine
at position 1316. Functional studies indicated that
CHC22
-V1316, which is more frequent in farming populations than in hunter-gatherers, has different cellular dynamics than M1316-
CHC22
and is less effective at controlling GLUT4 membrane traffic, altering its insulin-regulated response. These analyses suggest that ancestral human dietary change influenced selection of allotypes that affect
CHC22
's role in metabolism and have potential to differentially influence the human insulin response.
...
PMID:Genetic diversity of CHC22 clathrin impacts its function in glucose metabolism. 3115 24